###begin article-title 0
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 97 99 97 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 188 193 <span type="species:ncbi:10090">mouse</span>
Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 288 290 288 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 353 359 <span type="species:ncbi:10090">murine</span>
The present study was devised to understand the role of systemic indoleamine 2,3-dioxygenase (IDO) in the tolerance induction for orally tolerized mice in collagen-induced arthritis (CIA). We examined whether IDO-expressing dendritic cells (DCs) are involved in the generation of CD4+CD25+ regulatory T cells during the induction of oral tolerance in a murine CIA model.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 411 412 411 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 416 418 416 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Type II collagen was fed six times to DBA/1 mice beginning 2 weeks before immunization, and the effect on arthritis was assessed. To examine the IDO expression, the DCs of messenger RNA and protein were analyzed by RT-PCR and Flow cytometry. In addition, a proliferative response assay was also carried out to determine the suppressive effects of DCs through IDO. The ability of DCs expressing IDO to induce CD4+CD25+ T regulatory cells was examined.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 5 7 5 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 146 148 146 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 358 360 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 385 386 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 394 396 394 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
CD11c+ DCs in Peyer's patches from orally tolerized mice expressed a higher level of IDO than DCs from nontolerized CIA mice. IDO-expressing CD11c+ DCs were involved in the suppression of type II collagen-specific T-cell proliferation and in the downregulation of proinflammatory T helper 1 cytokine production. The suppressive effect of IDO-expressing CD11c+ DCs was mediated by Foxp3+CD4+CD25+ regulatory T cells.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Our data suggest that tolerogenic CD11c+ DCs are closely linked with the induction of oral tolerance through an IDO-dependent mechanism and that this pathway may provide a new therapeutic modality to treat autoimmune arthritis.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 716 717 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 721 723 718 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 732 733 729 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 734 736 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 737 739 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 947 949 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 992 993 989 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 997 999 994 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1067 1069 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 924 928 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
###xml 1061 1065 <span type="species:ncbi:10090">mice</span>
Repeated oral administration of autoantigen can suppress autoimmune responses in collagen-induced arthritis (CIA) and experimental autoimmune encephalomyelitis, and can suppress diabetes in nonobese diabetic mice [1-10]. Although the mechanisms responsible for the induction of oral tolerance have not been elucidated fully, repeated oral administration of a high dose of antigen can induce oral tolerance by anergy or deletion of antigen-specific T cells. In contrast, repeated feeding of a low dose of antigen favors the induction of active immune regulation involving regulatory T cells, including transforming growth factor beta (TGFbeta)-producing T helper 3 cells, IL-10-producing T regulatory 1 cells, and CD4+CD25+ T cells [1,10,11]. Previous studies have demonstrated that, after repeated oral administration of type II collagen (CII) and subsequent induction of CIA, the mean arthritis index is lower in tolerized mice than in CIA mice [12] and the proportion of IL-10-producing CD4+CD25+ T cells increases in Peyer's patches and spleens of tolerized mice [13]. Among the various immune cells involved in the induction of oral tolerance, dendritic cells (DCs) may play a major role in linking orally administered antigen to antigen-specific tolerance.
###end p 11
###begin p 12
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 346 348 346 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 483 484 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 488 490 488 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 515 516 515 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 524 526 520 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 570 572 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
DCs are professional antigen-presenting cells (APCs) that play a decisive role in determining immunity or immune tolerance; this determination is based on the maturation or activation state and the subset of DCs, and cytokine profiles in the microenvironment at the time of antigen uptake [1,14-16]. A previous study demonstrated that CD11c+CD11b+ DCs, which increase in number in Peyer's patches during the induction of tolerance to CII, suppress T-cell proliferation and induce CD4+CD25+ regulatory T cells. CD11c+CD8alpha+ DCs, however, promote T-cell proliferation [12]. The mechanisms underlying the suppression by DCs of the expansion and differentiation of effector T cells and promotion of T-cell tolerance remain elusive.
###end p 12
###begin p 13
###xml 277 286 277 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 290 298 290 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 468 476 468 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 612 614 612 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 891 893 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 894 896 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 897 899 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 179 185 <span type="species:ncbi:10090">Murine</span>
###xml 883 889 <span type="species:ncbi:9606">humans</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
One regulatory mechanism of DCs is the suppression of proliferation by producing the enzyme indoleamine 2,3-dioxygenase (IDO), which degrades the essential amino acid tryptophan. Murine macrophages and DCs expressing IDO inhibit T-cell proliferation or induce T-cell apoptosis in vitro and in vivo [17]. Munn and colleagues reported that plasmacytoid DCs in tumor-draining lymph nodes express IDO constitutively, which causes local immunosuppression and T-cell anergy in vivo [18,19]. Mellor and colleagues reported that systemic administration of CpG oligodeoxynucleotides induces IDO expression in splenic CD19+ DCs, which acquire regulatory functions in an IDO-dependent manner [20]. Upon exposure to allergen within the mucosa, Langerhans-like DCs expressing high-affinity IgE receptors produce IL-10 and TGFbeta, upregulate IDO expression, and suppress the allergic response in humans [16,21,22]. Whether the tolerogenic activity of DCs from Peyer's patches in orally tolerized mice is IDO dependent, however, is unknown.
###end p 13
###begin p 14
###xml 344 345 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 349 351 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
To elucidate the expression of IDO and its role in the induction of oral tolerance, we prepared DCs from Peyer's patches of DBA/1 mice after induction of oral tolerance by repeated oral administration of CII and subsequent induction of CIA. We examined whether IDO-expressing DCs have tolerogenic characteristics and whether they can induce CD4+CD25+ regulatory T cells. Our results demonstrate that IDO-expressing DCs in Peyer's patches play an essential role in the induction of oral tolerance in this model of autoimmune disease.
###end p 14
###begin title 15
Materials and methods
###end title 15
###begin title 16
Animals
###end title 16
###begin p 17
###xml 268 278 268 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum</italic>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 211 216 <span type="species:ncbi:10090">mouse</span>
Six-week-old to 8-week-old male DBA/1J mice (SLC, Inc., Shizuoka, Japan) were maintained in groups of two to four animals in polycarbonate cages in a specifically pathogen-free environment and were fed standard mouse chow (Ralston Purina, St Louis, MO, USA) and water ad libitum. All experimental procedures were examined and approved by the Animal Research Ethics Committee at the Catholic University of Korea.
###end p 17
###begin title 18
Preparation of type II collagen
###end title 18
###begin p 19
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
###xml 140 144 <span type="species:ncbi:9913">calf</span>
Bovine CII was kindly provided by Professor Andrew Kang of the University of Tennessee. CII was extracted in its native form from the fetal calf articular cartilage and was purified as described previously [23].
###end p 19
###begin title 20
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Induction of oral tolerance in DBA/1 mice
###end title 20
###begin p 21
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 47 53 <span type="species:ncbi:9913">bovine</span>
DBA/1 mice were sacrificed either with 100 mug bovine CII dissolved in 0.05 N acetic acid and 4 mg/ml solution of 25 mul CII solution + 175 mul PBS for the tolerance group or with an equal volume of an acetic acid-PBS mixture (25 mul of 0.05 N acetic acid + 175 mul PBS) for the CIA group. Administration was performed using an oral Zonde needle (Natsume, Tokyo, Japan) every 2 days over 2 weeks, beginning 2 weeks before immunization.
###end p 21
###begin title 22
Induction and evaluation of arthritis
###end title 22
###begin p 23
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
Bovine CII was dissolved in 0.05 N acetic acid to 4 mg/ml concentration and was emulsified (1:1 ratio) with complete Freund's adjuvant. As a primary immunization, 0.1 ml emulsion containing 100 mug CII was injected into the tail. Two weeks later, a booster injection of 100 mug CII dissolved similarly and emulsified 1:1 with incomplete Freund's adjuvant was administered to the hind leg.
###end p 23
###begin p 24
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
Starting 18 days after the primary immunization, three independent observers examined the severity of arthritis three times a week for up to 11 weeks. The severity of arthritis was recorded as the mean arthritic index on a 0 to 4 scale according to the following criteria [24]: 0 = no edema or swelling, 1 = slight edema and erythema limited to the foot or ankle, 2 = slight edema and erythema from the ankle to the tarsal bone, 3 = moderate edema and erythema from the ankle to the tarsal bone, and 4 = edema and erythema from the ankle to the entire leg. The sum of the values from three legs, excluding the hind leg into which CII-incomplete Freund's adjuvant was injected, was determined and divided by three to obtain an average. The final value represents the average recorded by three independent observers.
###end p 24
###begin title 25
Isolation of dendritic cells
###end title 25
###begin p 26
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Mononuclear cells from Peyer's patches were incubated with anti-mouse CD11c-coated magnetic beads (Miltenyi Biotec, Auburn, CA, USA) and then subjected to positive selection through magnetic-activated cell sorting. Separated cells routinely showed >98% viable DCs.
###end p 26
###begin title 27
Determination of the type II collagen-specific T-cell proliferative response
###end title 27
###begin p 28
###xml 560 562 548 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 684 686 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 697 699 684 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 823 825 810 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 840 842 827 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 876 878 863 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 1119 1120 1104 1105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 666 671 <span type="species:ncbi:10090">mouse</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
Mice were killed 5 weeks after primary immunization. The Peyer's patches were removed, treated for 90 minutes at 37degreesC with media containing dithiothreitol and ethylenediamine tetraacetic acid to remove epithelial cells, and washed extensively with Hanks' balanced salt solution. The Peyer's patches were then digested with collagenase D and DNase, and were incubated in the presence of 5 mM ethylenediamine tetraacetic acid for 5 minutes at 37degreesC. Prepared mononuclear cells were then plated in 96-well microtiter plates at a concentration of 2 x 105 cells/well and cultured for 3 days with 40 mug/well CII in 0.3 ml Click's medium supplemented with 0.5% mouse serum. CD11c+ DCs (1 x 104 cells) isolated from Peyer's patch mononuclear cells of tolerized or CIA mice were cultured for 3 days with CII-reactive CD4+ T cells (1 c 105 cells) and irradiated APCs (1 x 105 cells) obtained from Peyer's patch cells of CIA mice. Cells were pretreated with the IDO-specific inhibitor 1-methyl tryptophan (1-MT) (200 muM) for 2 hours before CII stimulation. Eighteen hours before the termination of culture, 0.5 muCi [3H]thymidine (New England Nuclear, Boston, MA, USA) was added to each well. Cells were harvested onto glass fiber filters and were counted in a Matrix-96 direct ionization counter (Packard Instrument Co., Downers Grove, IL, USA). Data are presented as the mean counts per minute (cpm) of triplicate cultures.
###end p 28
###begin p 29
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 80 82 80 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 243 245 242 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 260 262 259 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 296 298 295 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 385 386 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
Various numbers of CD4+CD25+ T cells that had been expanded by exposure to CD11c+ DCs from Peyer's patches of tolerized mice in the presence of CII stimulation were cultured for 3 days in the presence of CII (40 mug/well) with CII-reactive CD4+ T cells (1 x 105 cells) and irradiated APCs (1 x 105 cells) obtained from CIA mice. Proliferative responses were measured as the amount of [3H]thymidine incorporated during the last 18 hours of incubation.
###end p 29
###begin title 30
Reverse transcription-polymerase chain reaction analysis of indoleamine 2,3-dioxygenase and Foxp3 expression
###end title 30
###begin p 31
Total RNA (2 mug) was reverse transcribed into cDNA using a transcription kit (TaqMan Reverse Transcription Reagents; Applied Biosystems, Darmstadt, Germany). The resulting cDNA was amplified by PCR using IDO sense (5'-CACTGTACCAGTGCAGTAG-3') and antisense (5'-ACCATTCACACACT CGTTAT-3') primers, and using Foxp3 sense (5'-CAGCTGCCTACAGTGCCCCTAG-3') and antisense (5'-CATTTGCCACGAGTGGGTAG-3') primers. PCR products were separated on a 1.5% agarose gel and stained with ethidium bromide. Fragments of 472 bp for IDO and 390 bp for Foxp3 were obtained.
###end p 31
###begin title 32
Detection of cytokine production by enzyme-linked immunosorbent assay
###end title 32
###begin p 33
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 81 83 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
CD4+ T cells isolated from Peyer's patches of CIA mice were cocultured with CD11c+ DCs from tolerized mice or CIA mice in the absence or presence of CII (40 mug/well). Cells were pretreated for 2 hours with 1-MT (200 muM). After 2 days, the culture medium was harvested from each well and stored at -70degreesC. The concentrations of IL-17, IL-10, and TGFbeta in the culture supernatant were measured by sandwich ELISA.
###end p 33
###begin title 34
Flow cytometric analysis of intracellular indoleamine 2,3-dioxygenase and regulatory T cells
###end title 34
###begin p 35
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 302 308 <span type="species:ncbi:9986">rabbit</span>
###xml 406 410 <span type="species:ncbi:9925">goat</span>
###xml 416 422 <span type="species:ncbi:9986">rabbit</span>
###xml 538 544 <span type="species:ncbi:9986">Rabbit</span>
Single mononuclear cells were prepared from Peyer's patches of tolerized and CIA mice, stained with Fluorescein isothiocyanate-labeled anti-CD11c mAb, permeabilized, and fixed with CytoPerm/CytoFix (Pharmingen, BD, San Diego, CA, USA) as instructed by the manufacturer. Cells were stained further with rabbit anti-IDO polyclonal antibody (Transgenic Inc, Kobe, Japan), followed by Phycoerythrin-conjugated goat anti-rabbit immunoglobulin, and then subjected to flow cytometric analysis (FACSCalibur; Becton Dickinson, San Jose, CA, USA). Rabbit IgG was used as the corresponding isotype antibody control.
###end p 35
###begin p 36
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 19 21 19 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 341 343 341 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 354 356 354 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 467 468 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 472 474 472 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 489 491 489 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 636 637 636 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 641 643 641 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 655 657 655 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 733 738 <span type="species:ncbi:10090">mouse</span>
###xml 776 781 <span type="species:ncbi:10090">mouse</span>
###xml 840 845 <span type="species:ncbi:10090">mouse</span>
###xml 880 883 <span type="species:ncbi:10116">rat</span>
To isolate CD4+CD25- T cells, mononuclear cells from Peyer's patches from tolerized mice were stained with a mixture of anti-CD4 PerCP and CD25 allophycocyanin mAbs (Pharmingen, BD) and were sorted using the Vantage FACSorter (BD Bioscience, San Diego, CA). The purity of the sorted cells was 95% to 99% as evaluated by flow cytometry. CD11c+ DCs (1 x 104 cells) isolated from Peyer's patch mononuclear cells of tolerized or CIA mice were cultured for 3 days with CD4+CD25- T cells (1 x 105 cells) obtained from Peyer's patch cells of tolerized mice in the presence or absence of CII. To measure the amount of intracellular Foxp3 in CD4+CD25+ T cells, CD4+ T cells and DCs were cocultured and surface-stained with PerCP-labeled anti-mouse CD4 and allophycocyanin-labeled anti-mouse CD25, and then with 0.5 mug Phycoerythrin-conjugated anti-mouse Foxp3 or Phycoerythrin-conjugated rat IgG2a isotype control using the regulatory T Cell Staining Kit (eBioscience, San Diego, CA, USA).
###end p 36
###begin title 37
Confocal microscopy
###end title 37
###begin p 38
Intracellular immunofluorescence staining was performed using the intracellular flow cytometric method described above. The cells were allowed to adhere to the glass slide using a Shandon CytoSpin III cytocentrifuge (GMI, Ramsey, MN, USA). The slides were then mounted using fluorescent mounting medium (Dako, Trappes, France). Confocal analysis was performed with a confocal laser scanning microscope (LSM 510 meta; Carl Zeiss, Heidelberg, Germany) equipped with a krypton-argon mixed-gas laser as the light source.
###end p 38
###begin title 39
Statistical analysis
###end title 39
###begin p 40
###xml 118 120 118 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U </italic>
###xml 347 349 345 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 381 383 379 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The arthritis scores at the different times were compared between the two groups using the nonparametric Mann-Whitney U test. All data are expressed as the mean +/- standard deviation. Statistical analysis was performed using SPSS 10.0 for Windows (SPSS, Chicago, IL, USA). The differences between groups were analyzed using an unpaired Student's t test, assuming equal variances. P < 0.05 was considered significant.
###end p 40
###begin title 41
Results
###end title 41
###begin title 42
Repeated oral administration of type II collagen induces immune tolerance and inhibits arthritis development
###end title 42
###begin p 43
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
The arthritis index remained low in both the tolerance and CIA groups until 4 weeks after primary immunization with CII-complete Freund's adjuvant. In the CIA group, the arthritis index began to increase after week 5, reached a peak between weeks 6 and 9 after primary immunization, and then decreased by week 11. In the tolerance group, the arthritis index peaked between weeks 6 and 9, but the index was significantly lower than that of the CIA group throughout the examination period (Figure 1).
###end p 43
###begin p 44
###xml 760 762 757 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 772 774 769 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 55 59 <span type="species:ncbi:10090">Mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
Inhibition of arthritis development in tolerized mice. Mice in the tolerance group were fed 100 mug type II collagen (CII) six times for 2 weeks before immunization. For collagen-induced arthritis (CIA) induction, CII emulsified with complete Freund's adjuvant was injected into the tail of mice in the tolerance group and in the CIA group as a primary immunization. Two weeks later, CII emulsified with incomplete Freund's adjuvant was injected into a hind leg as a booster injection. The mean arthritis index was significantly lower in the tolerance group than in the CIA group throughout the examination period. Values are presented as the mean +/- standard deviation of three independent experiments involving 20 tolerized mice and 20 CIA mice per group. *P < 0.05, **P < 0.005.
###end p 44
###begin title 45
###xml 100 102 100 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
Induction of oral tolerance increases the proportion of indoleamine 2,3-dioxygenase-expressing CD11c+ dendritic cells in Peyer's patches of tolerized mice
###end title 45
###begin p 46
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 343 345 343 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 360 362 360 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
DCs are potent stimulators of naive T cells and are key inducers of immune tolerance [25]. One molecular mechanism by which DCs regulate T cells is through the expression of IDO, which degrades the essential amino acid tryptophan [26]. To determine whether IDO expression increases in tolerized mice, we examined the relative proportion of IDO+ DCs among CD11c+ DCs in Peyer's patches after repeated oral administration of CII and subsequent CIA induction.
###end p 46
###begin p 47
###xml 146 148 142 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 220 222 216 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 241 243 235 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 275 277 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 349 351 343 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 483 485 477 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 615 617 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
IDO expression was significantly higher in DCs from tolerized mice than in CIA mice (mean fluorescence index, 87.4 +/- 11.2 versus 36.7 +/- 10.2, P < 0.05). Normal DBA/1 mice had the lowest mean fluorescence index of IDO+ DCs (10.2 +/- 5.2, P < 0.05; data not shown) (Figure 2a). These data were confirmed by measuring the mRNA level of IDO in CD11c+ DCs obtained from Peyer's patches of tolerized and CIA mice. We used semiquantitative RT-PCR to measure IDO mRNA expression in CD11c+ DCs isolated from Peyer's patches. The IDO transcripts were upregulated markedly in tolerized mice compared with CIA mice (Figure 2b).
###end p 47
###begin p 48
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 219 221 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 281 285 281 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 325 327 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 705 707 705 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 917 921 915 919 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 988 990 986 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1153 1154 1148 1149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1297 1299 1290 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1307 1311 1300 1304 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 1388 1390 1381 1383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 615 620 <span type="species:ncbi:10090">mouse</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
###xml 977 981 <span type="species:ncbi:10090">mice</span>
###xml 1464 1468 <span type="species:ncbi:10090">mice</span>
Oral tolerance induction in indoleamine 2,3-dioxygenase-expressing CD11c+ dendritic cells of tolerized mice. The induction of oral tolerance increases the proportion of indoleamine 2,3-dioxygenase (IDO)-expressing CD11c+ dendritic cells (DCs) in Peyer's patches of tolerized mice. (a) Flow cytometric analysis of IDO in CD11c+ DCs isolated from Peyer's patches. Mononuclear cells obtained from Peyer's patches of tolerized mice and of CIA mice were probed with Fluorescein isothiocyanate-labeled anti-CD11c mAb and were fixed with CytoPerm/CytoFix for 20 minutes. Cells were probed for intracellular IDO using anti-mouse IDO antibody and were analyzed by flow cytometry. The histograms were gated on CD11c+ DCs. Dotted histogram lines represent cells stained with isotype-matched control monoclonal antibodies. Results are the mean +/- standard deviation of replicate samples from seven independent experiments. SSC. (b) Analysis of IDO transcription in tolerized mice and CIA mice. CD11c+ DCs were isolated from Peyer's patch mononuclear cells using the magnetic-activated cell sorting system. The expression of IDO mRNA was analyzed using RT-PCR. beta2-Actin was used as an internal control. Each value is the mean +/- standard deviation of replicate determinations in one of four experiments. *P < 0.05. (c) Immunofluorescent confocal microscopic examination of IDO expression by CD11c+ DCs. Mononuclear cells obtained from Peyer's patches of tolerized and CIA mice were stained with Fluorescein isothiocyanate-labeled anti-CD11c (green) and anti-IDO (red), fixed, and were examined using confocal microscopy. Isotype-matched control antibody staining was negative (data not shown). Data are representative of three independent experiments.
###end p 48
###begin p 49
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 255 257 255 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
Using confocal microscopy, we identified the expression of IDO in situ at the single-cell level. Single cells were stained simultaneously with a pandendritic cell marker, anti-CD11c (green), and an IDO-specific antibody (red). About one-third of the CD11c+ DCs from tolerized mice expressed IDO (yellow). In contrast, the DCs from CIA mice rarely expressed IDO (Figure 2c).
###end p 49
###begin title 50
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Indoleamine 2,3-dioxygenase-expressing CD11c+ dendritic cells have an immature phenotype
###end title 50
###begin p 51
###xml 9 11 9 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 74 75 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 81 85 81 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 97 102 97 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 217 226 217 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 230 237 230 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
Human IDO+ DCs show a mature phenotype characterized by CD14-, CD83+, CD80+, CD86high, and HLA-DRhigh [27,28]. In contrast, DCs expressing IDO in mice show an immature phenotype and suppress T-cell proliferation both in vitro and in vivo. The maturational status of IDO-expressing DCs in Peyer's patches of tolerized mice, however, has never been considered.
###end p 51
###begin p 52
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 95 97 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 140 142 140 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 145 147 145 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
We examined the expression of major histocompatibility complex II, CD80, and CD86 by CD11c+ IDO+ DCs from tolerized mice and CIA mice. CD11c+ IDO+ DCs from tolerized mice expressed low levels of MHC II and CD86, suggesting an immature phenotype. In contrast, the expression of these surface molecules was significantly higher on DCs from CIA mice, which is characteristic of mature DCs (Figure 3). The expression of CD80, however, did not differ significantly between the two groups.
###end p 52
###begin p 53
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 151 152 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 157 159 157 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 456 457 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 462 464 462 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Indoleamine 2,3-dioxygenase-expressing CD11c+ dendritic cells display a phenotype consistent with the immature state. Indoleamine 2,3-dioxygenase (IDO)+CD11c+ dendritic cells (DCs) were stained for markers of DC maturity and were analyzed using three-color flow cytometry. Mononuclear cells from Peyer's patches were stained for CD11c, IDO, and Major Histocompatibility Complex (MHC) II, or costimulatory molecule markers. All plots were first gated on IDO+CD11c+ cells. Dotted line shows the isotype-matched controls. Data are the mean +/- standard deviation of three experiments. MFI, mean fluorescence index.
###end p 53
###begin title 54
###xml 5 7 5 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
CD11c+ dendritic cells of tolerized mice inhibit type II collagen-specific T-cell proliferation in an indoleamine 2,3-dioxygenase-dependent manner
###end title 54
###begin p 55
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 486 488 486 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 591 593 591 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
APC-induced T-cell activation requires contact-dependent bidirectional signaling between the APCs and the T cells [29]. This signaling may upregulate IDO expression in DCs, and this may control autoreactive T cells by depleting tryptophan [25,30]. We explored whether IDO affects the ability of DCs isolated from Peyer's patches of tolerized mice to regulate T-cell responses. Mixed lymphocyte cultures were performed in the presence or absence of the IDO-specific inhibitor 1-MT. CD11c+ DCs from Peyer's patches of tolerized mice or CIA mice were cocultured for 3 days with CII-reactive CD4+ T cells and irradiated APCs obtained from CIA mice in the absence or presence of CII.
###end p 55
###begin p 56
###xml 62 64 62 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 99 101 99 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 157 159 157 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 239 241 235 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 257 259 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 343 345 339 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 389 391 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 413 415 409 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 439 441 435 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 514 516 510 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 543 545 539 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 605 607 597 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 702 704 694 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 776 778 768 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 807 809 797 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 822 824 810 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
Without CII stimulation, the proliferation of CII-reactive CD4+ T cells was inhibited more by CD11c+ DCs from Peyer's patches of tolerized mice than by CD11c+ DCs from Peyer's patches of CIA mice (687 +/- 159 cpm versus 1,257 +/- 103 cpm, P < 0.05) (Figure 4a). With CII-specific stimulation, the suppressive effect was more prominent in CD11c+ DCs from tolerized mice. As shown in Figure 4a, proliferation of CD4+ T cells induced by CD11c+ DCs of tolerized mice was suppressed to be about one-third of that in CD4+ T cells cultured with CD11c+ DCs of CIA mice (1,507 +/- 817 cpm versus 4,204 +/- 95 cpm, P < 0.05). Addition of the IDO inhibitor 1-MT, however, abolished the suppressive effect of CD11c+ DCs from tolerized mice on CII-specific T-cell proliferation (1,507 x 103 +/- 817 cpm versus 3,128 x 103 +/- 101 cpm, P < 0.05). Without CII stimulation, 1-MT had no significant effect on T-cell proliferation in either group.
###end p 56
###begin p 57
###xml 20 22 20 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 145 149 145 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 184 186 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 201 202 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 263 264 263 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 366 368 366 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 397 398 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 777 779 773 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 787 791 783 787 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 1056 1058 1047 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1068 1070 1059 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
Tolerized mice CD11c+ dendritic cells induce indoleamine 2,3-dioxygenase-dependent inhibition of type II collagen-specific T-cell proliferation. (a) Type II collagen (CII)-reactive CD4+ T cells (1 x 105/well) and irradiated antigen-presenting cells (APCs) (1 x 105/well) isolated from Peyer's patches of collagen-induced arthritis (CIA) mice were cultured with CD11c+ dendritic cells (DCs) (1 x 104/well) from tolerized mice or CIA mice in the presence or absence of CII (40 mug/ml) in 96-well, U-bottomed plates for 3 days. Some DCs were pretreated with 1-methyl tryptophan (1-MT) (200 muM) for 2 hours before coculture. Data presented as the mean counts per minute (cpm) of triplicate cultures. Values are the mean +/- standard deviation from three independent experiments. *P < 0.05. (b) Cytokine concentrations in the coculture supernatants. Concentrations of IL-17, IL-10, and transforming growth factor beta (TGFbeta) in the culture supernatants were measured by ELISA. Values are the mean +/- standard deviation from three independent experiments. *P < 0.05, **P < 0.001.
###end p 57
###begin p 58
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 276 278 276 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 333 335 333 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 424 426 420 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 442 444 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 577 579 573 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 626 628 618 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 761 763 750 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 818 820 807 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 885 887 870 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 951 953 929 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1127 1129 1098 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1193 1195 1157 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1244 1246 1208 1210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
To investigate the effect of IDO on the suppression of antigen-specific T cells exerted by CD11c+ DCs from tolerized mice, cytokine concentrations were measured in the coculture supernatants. The IL-17 concentration was significantly lower in the culture supernatants of CD11c+ DCs of tolerized mice than in the supernatants of CD11c+ DCs of CIA mice cultured in the presence of CII (82 +/- 17 pg/ml versus 158 +/- 9 pg/ml, P < 0.05) (Figure 4b). Addition of 1-MT into the coculture in the presence of CII, however, markedly increased the production of IL-17 by tolerized CD11c+ DCs (from 82 +/- 17 pg/ml to 141 +/- 15 pg/ml, P < 0.01). The concentrations of anti-inflammatory cytokines such as IL-10 and TGFbeta were higher in the culture supernatants of CD11c+ DCs of tolerized mice than in the supernatants of CD11c+ DCs of CIA mice (IL-10, 131 +/- 14 pg/ml versus 79 +/- 13 pg/ml (P < 0.05); and TGFbeta, 260 +/- 11 pg/ml versus 195 +/- 16 pg/ml (P < 0.05)). The addition of 1-MT, however, significantly decreased the production of IL-10 and TGFbeta in the tolerance group (IL-10, from 131 +/- 14 pg/ml to 92 +/- 16 pg/ml (P < 0.05); and TGFbeta, from 260 +/- 11 pg/ml to 126 +/- 9 pg/ml (P < 0.05)), suggesting that IDO expression on CD11c+ DCs plays an important role in immune suppression.
###end p 58
###begin title 59
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 94 96 94 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Indoleamine 2,3-dioxygenase-dependent induction of antigen-specific CD4+CD25+ T cells by CD11c+ dendritic cells in tolerized mice
###end title 59
###begin p 60
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 336 338 336 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 464 465 464 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 469 471 469 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 517 518 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 523 525 523 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 638 639 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 643 645 643 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 728 729 728 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 733 735 733 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 813 815 813 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 892 893 892 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 897 899 897 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 924 926 924 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 987 989 987 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1104 1105 1100 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1109 1111 1105 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 245 251 <span type="species:ncbi:10090">murine</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
###xml 841 845 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
###xml 1002 1006 <span type="species:ncbi:10090">mice</span>
Regulatory APCs may form a bridge between regulatory T cells and responder T cells, and this has been proposed as a mechanism contributing to the phenomenon of linked suppression and dominant tolerance [26]. Experimental evidence indicates that murine regulatory T cells can induce the expression of IDO [31]. We hypothesized that CD11c+ DCs in tolerized mice are likely to be the IDO-dependent biologically relevant trigger for the generation or conversion of CD4+CD25+ regulatory T cells. In a previous study, CD11c+CD11b+ DCs isolated from Peyer's patches of tolerized mice seemed necessary for the expansion and differentiation of CD4+CD25+ T cells, which suppress CII-specific T-cell proliferation [12]. Highly purified CD4+CD25- T cells isolated from tolerized mice (purity > 99%) were cocultured with CD11c+ DCs from tolerized or CIA mice for 3 days, without CII. The proportion of CD4+CD25+ T cells expanded by CD11c+ DCs from tolerized mice was similar to that obtained by CD11c+ DCs from CIA mice (4.65% +/- 0.66% versus 3.68% +/- 0.46%). 1-MT had no significant effect on the proportion of CD4+CD25+ T cells in these systems (4.74% +/- 0.91% versus 3.56% +/- 0.33%).
###end p 60
###begin p 61
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 56 58 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 103 105 103 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a,b</xref>
###xml 220 221 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 225 227 225 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 252 253 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 257 259 257 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 288 290 288 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 348 349 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 353 355 353 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 384 386 384 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 445 447 441 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 508 509 504 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 513 515 509 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 539 541 535 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 612 614 606 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 719 720 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 724 726 716 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 742 743 734 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 747 749 739 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 799 800 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 804 806 796 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 846 848 838 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 979 981 971 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1103 1105 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c</xref>
###xml 1190 1191 1182 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1195 1197 1187 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1213 1214 1205 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1218 1220 1210 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1236 1238 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5d</xref>
###xml 1283 1284 1275 1276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1288 1290 1280 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1323 1324 1315 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1328 1330 1320 1322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1335 1337 1327 1329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
###xml 1367 1371 <span type="species:ncbi:10090">mice</span>
We next examined whether IDO would induce naive CD4+CD25- T cells to differentiate into CD4+CD25+ Foxp3+ T cells in an antigen-specific manner when cocultured with CD11c+ DCs. Figure 5a,b shows that the percentage of CD4+CD25+ T cells was higher in CD4+CD25- T cells cocultured with CD11c+ DCs from tolerized mice in the presence of CII than in CD4+CD25- T cells cocultured with CD11c+ DCs from CIA mice (13.4% +/- 1.89% versus 5.56% +/- 0.22%, P < 0.05). 1-MT abrogated the increase in the proportion of CD4+CD25+ T cells induced by CD11c+ DCs from tolerized mice (5.67% +/- 0.72%) but not that induced by CD11c+ DCs from CIA mice (5.41% +/- 0.20%). We used flow cytometry to investigate the possible conversion of CD4+CD25- T cells into CD4+CD25+ T cells in concomitance with Foxp3 appearance. CD4+CD25+ T cells obtained by coculture with CD11c+ DCs from tolerized mice expressed significantly higher levels of Foxp3 expression than those cells obtained by coculture with CD11c+ DCs from CIA mice; this effect was diminished by the addition of 1-MT (CII stimulation, 72.1%; CII + 1-MT, 32.1%) (Figure 5c). Using RT-PCR, we also examined Foxp3 transcripts involved in the conversion of CD4+CD25- T cells into CD4+CD25+ T cells (Figure 5d). Our findings show that highly purified CD4+CD25- T cells can be converted into CD4+CD25+ Foxp3+ T cells by DCs from tolerized mice by CII-specific stimulation through an IDO-dependent mechanism.
###end p 61
###begin p 62
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 101 103 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 150 154 150 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 167 168 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 172 174 172 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 303 304 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 308 310 308 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 325 326 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 357 359 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 388 389 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 614 615 613 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 619 621 618 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 725 729 724 728 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 762 763 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 767 769 766 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 958 960 957 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 968 972 967 971 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 1017 1018 1016 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1022 1024 1021 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1056 1057 1055 1056 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1061 1063 1060 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1270 1274 1267 1271 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 1332 1333 1326 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-</italic>
###xml 1432 1436 1426 1430 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 1478 1479 1472 1473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1483 1485 1477 1479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1497 1498 1491 1492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1502 1504 1496 1498 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1546 1548 1540 1542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1659 1660 1653 1654 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1664 1666 1658 1660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1720 1722 1714 1716 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1737 1738 1731 1732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1787 1788 1781 1782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1925 1927 1916 1918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1937 1939 1928 1930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 1588 1592 <span type="species:ncbi:10090">mice</span>
###xml 1795 1799 <span type="species:ncbi:10090">mice</span>
Indoleamine 2,3-dioxygenase-expressing CD11c+ dendritic cells essential for antigen-specific CD4+CD25+ regulatory T-cell induction in tolerized mice. (a) Increased CD4+CD25+ T-cell proportion through an indoleamine 2,3-dioxygenase (IDO)-dependent mechanism. For regulatory T-cell induction, isolated CD4+CD25- T cells (1 x 105/well) were cultured with CD11c+ dendritic cells (DCs) (2 x 104/well) from tolerized mice or collagen-induced arthritis (CIA) mice in the absence or presence of type II collagen (CII) (40 mug/ml) for 3 days. 1-Methyl tryptophan (1-MT) was added to selected cultures. The proportion of CD4+CD25+ T cells was determined using flow cytometry. Numbers represent the percentage of double-positive cells. (b) Summary of the percentages of CD4+CD25+ T cells from the coculture experiments in (a). Values are the mean from four independent experiments; individual symbols are the mean in individual animals, and bars show the group means. *P < 0.02. (c) Analysis of Foxp3 expression by converted CD4+CD25+ T cells. Plots were gated on CD4+CD25+ DCs. Dotted histogram lines represent cells stained with isotype-matched control monoclonal antibodies. Data represent the mean +/- standard deviation and are representative of four independent experiments. (d) Foxp3 mRNA expression in the same conditions as (a). beta -Actin was used as an internal control. Results are representative of four independent experiments. (e) Regulatory function of the CII-induced CD4+CD25+ T cells. CD4+CD25+ T cells were expanded by exposure to CD11c+ DCs from Peyer's patches from tolerized mice in the presence of CII antigen stimulation. Varying numbers of CD4+CD25+ T cells were cultured for 3 days with CII-reactive CD4+ T cells (1 x 105) and irradiated antigen-presenting cells (1 x 105) from mice with CIA in the presence of CII (40 mug/ml). Values are the mean +/- standard deviation from three independent experiments. *P < 0.05, **P < 0.001. cpm, counts per minute.
###end p 62
###begin p 63
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 58 60 58 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 132 134 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 170 172 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 233 235 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 319 320 319 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 324 326 324 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 350 352 350 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 412 414 412 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5e</xref>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
To verify that the increased population of CD4+CD25+ Foxp3+ T cells retained their suppressive function, varying numbers of CD4+CD25+ T cells induced by exposure to CD11c+ DCs from tolerized mice were cocultured with CII-reactive CD4+ T cells and irradiated APCs from CIA mice for 3 days in the presence of CII. The CD4+CD25+ T cells induced by CD11c+ DCs inhibited the proliferative response of CII-reactive CD4+ T cells in a concentration-dependent manner (Figure 5e).
###end p 63
###begin title 64
Discussion
###end title 64
###begin p 65
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
Oral tolerance is initiated in the gut-associated lymphoid tissues, a well-developed immune network in the alimentary tract that comprises the mucosal epithelium, lamina propria, Peyer's patches, and mesenteric lymph nodes [1,2]. Peyer's patches are essential sites for the induction of mucosal immune responses and oral tolerance to soluble antigen, and Peyer's patch DCs are thought to play an important role in mucosal immunity and tolerance [1-4]. The selection between immunity and tolerance depends on several factors, including the occurrence of specialized DC subsets and the maturation state of the DCs [1,12]. One mechanism, exploited by tolerogenic DCs, involves IDO [17-21]. IDO-competent DCs exert regulatory effects on T cells that are mediated by tryptophan depletion and by the production of metabolic byproducts collectively known as kynurenines [16,21,22].
###end p 65
###begin p 66
###xml 315 317 315 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 475 477 475 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 480 482 480 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1023 1030 1023 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 1170 1172 1170 1172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 241 247 <span type="species:ncbi:10090">murine</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 922 926 <span type="species:ncbi:10090">mice</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
###xml 1125 1129 <span type="species:ncbi:10090">mice</span>
###xml 1220 1224 <span type="species:ncbi:10090">mice</span>
Demonstrating the concomitant induction of IDO enzymatic activity by DCs, our data support IDO-dependent mechanisms that have been associated with induction of T-cell tolerance and immune inhibition in the induction of oral tolerance in the murine CIA model. We examined the change in the expression of IDO in CD11c+ DCs of Peyer's patches after repeated oral administration of CII and subsequent induction of CIA. In freshly isolated Peyer's patches, the proportion of CD11c+ IDO+ DCs was higher in tolerized mice than that in CIA mice. We found that IDO expression was induced most by oral CII feeding plus CII immunization, and that the expression of IDO did not correlate with disease severity. Next, we investigated whether the expression of IDO by DCs takes place during the initial phase of oral CII feeding or after the immunization with CII for CIA induction. In these studies, Peyer's patches were isolated from mice that had been fed with CII or PBS but not immunized with CII. We examined the expression of IDO in situ. The expression of IDO by DCs increased in Peyer's patches of CII-fed mice, even though these mice had not been immunized. In contrast, IDO+ DCs were rare in the Peyer's patches of PBS-fed mice (data not shown). Our results show that IDO is induced by oral CII feeding and enhances the induction of immune tolerance after oral administration of antigens.
###end p 66
###begin p 67
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 132 134 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 236 244 236 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
The immunosuppressive mechanism of IDO is shared by several different cell types in the immune system [30,32-36]. Splenic CD11c+CD19+ DCs found in the mice administered CpG oligodeoxynucleotides, human monocyte-derived macrophages, and in vitro-derived DCs induce IDO expression and inhibit T-cell proliferation. In this regard, it will be interesting to investigate IDO expression in different subsets of DCs from tolerized mice and to characterize their role in the induction and maintenance of immune tolerance.
###end p 67
###begin p 68
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 441 442 437 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 497 499 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 500 502 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 295 300 <span type="species:ncbi:9606">human</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
Tolerogenic DCs are immature, maturation-resistant, or alternatively activated DCs that express surface MHC molecules and have a low ratio of costimulatory to inhibitory signals, such as IL-10, programmed death-ligand 1, CTLA4/CD28, and IDO [37,38]. IDO expression is detected constitutively in human regulatory plasmacytoid DCs and can be induced by classical DC maturation stimuli, namely IFNgamma and lipopolysaccharide or prostaglandin E2, which contribute to their immunoregulatory capacity [37-40]. In our study, the phenotype of DCs from tolerized mice showed an immature tolerogenic state and low levels of surface MHC II and CD86 molecules, and expressed high levels of IDO compared with DCs from CIA mice. Our study suggests that IDO is expressed constitutively in immature DCs upon repeated oral administration of CII in an animal model without artificial administration of CTLA-4 immunoglobulin or other DC-modifying agents.
###end p 68
###begin p 69
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
Because IDO expression on DCs plays a crucial role in the induction of regulatory T cells and inhibition of the antigen-specific T-cell response, we performed mixed lymphocyte cultures to determine whether DCs isolated from Peyer's patches of tolerized mice and CIA mice have an IDO-dependent effect on CII-specific T cells. DCs from the tolerized mice inhibited the proliferation of CII-specific T cells and inflammatory cytokine production compared with DCs from CIA mice, and these suppressive effects were more evident after CII stimulation and were abrogated by addition of 1-MT, an IDO inhibitor. These findings suggest that the functional activities of IDO from tolerized mice could affect the T-cell response.
###end p 69
###begin p 70
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 274 276 274 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 418 419 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 423 425 423 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 657 659 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 712 713 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 717 719 713 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 776 778 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 848 850 844 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 901 902 897 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 906 908 902 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 953 954 949 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 987 988 983 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 992 994 988 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1046 1047 1042 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1051 1053 1047 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1071 1073 1067 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1209 1210 1205 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1214 1216 1210 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1243 1245 1239 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1317 1319 1313 1315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1387 1388 1383 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1392 1394 1388 1390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1504 1505 1500 1501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1509 1511 1505 1507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1568 1569 1564 1565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1573 1575 1569 1571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1642 1643 1638 1639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1647 1649 1643 1645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1688 1689 1684 1685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1693 1695 1689 1691 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1730 1732 1726 1728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1752 1753 1748 1749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1757 1759 1753 1755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1798 1799 1794 1795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1803 1805 1799 1801 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1822 1824 1818 1820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1918 1927 1914 1923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1991 1992 1987 1988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1995 1996 1991 1992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2000 2002 1996 1998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2102 2104 2098 2100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
###xml 1092 1096 <span type="species:ncbi:10090">mice</span>
###xml 1262 1266 <span type="species:ncbi:10090">mice</span>
###xml 1332 1336 <span type="species:ncbi:10090">mice</span>
###xml 1841 1845 <span type="species:ncbi:10090">mice</span>
In the resting state, autoreactive T cells residing in the periphery are suppressed effectively by regulatory T cells, which are thought to prevent the development of autoimmune diseases [39]. Our group previously demonstrated that the proportion of IL-10-producing CD4+CD25+ T cells increases more in Peyer's patches and spleens of tolerized mice than in those of CIA mice [12]. Bozza and colleagues reported that CD4+CD25+ regulatory T cells in candidiasis are strictly dependent on the expression of B7 costimulatory molecules by IL-10-producing DCs, and are involved in the IFNgamma/IDO-dependent pathway that controls the local inflammatory pathology [39]. Saito and colleagues also found that CTLA-4 on CD4+CD25+ regulatory T cells induces the expression of IDO on DCs [40]. Considering these findings, we next sought to determine whether IDO+ DCs increase the proportion of antigen-specific CD4+CD25+ regulatory T cells in tolerized mice. Figure 5 shows that the percentage of CD4+CD25+ cells increased significantly after coculture of CD4+CD25- T cells with CD11c+ DCs from tolerized mice in the presence of CII through an IDO-dependent mechanism. In the absence of CII, however, the proportion of CD4+CD25+ cells cocultured with CD11c+ DCs of tolerized mice was similar to that in cells cocultured with CD11c+ DCs from CIA mice. This result suggests that the conversion into CD4+CD25+ T cells without CII stimulation result from the IDO-independent expansion or selected survival of residual CD4+CD25+ T cells. Foxp3 is a transcription factor specific for CD4+CD25+ regulatory T cells. Foxp3 may be necessary for the induction of CD4+CD25+ regulatory T cells by conversion of CD4+CD25- T cells after antigen stimulation [41]. We found that CD4+CD25+ T cells obtained after coculture of CD4+CD25- T cells and CD11c+ DCs of tolerized mice with CII expressed a large amount of Foxp3 transcript and Foxp3 protein in vitro in an IDO-dependent manner. In addition, the conversion of Foxp3+CD4+CD25+ T cells, which are thought to be regulatory T cells, inhibited the proliferation of CII-reactive CD4+ T cells in a dose-dependent manner.
###end p 70
###begin p 71
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 8 10 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 63 65 63 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 293 302 287 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 303 305 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 379 380 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 383 384 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 388 390 382 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 491 492 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 496 498 490 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 554 555 548 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 559 561 553 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 579 580 573 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 583 584 577 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 588 590 582 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
CD4+CD25+ regulatory T cells converted from peripheral CD4+CD25- naive T cells by TGFbeta induction of Foxp3 were reported to be unresponsive to T-cell receptor stimulation, to produce neither T helper 1 nor T helper 2 cytokines, to express TGFbeta, and to inhibit normal T-cell proliferation in vitro [42]. Different to this regulatory T-cell population, we found that the Foxp3+CD4+CD25+ T cells in our model system may result partly from the expansion or selected survival of residual CD4+CD25+ regulatory T cells and partly from the conversion of CD4+CD25- T cells into Foxp3+CD4+CD25+ regulatory T cells through an IDO-dependent mechanism.
###end p 71
###begin title 72
Conclusion
###end title 72
###begin p 73
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 68 70 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 224 226 224 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
IDO expression by DCs is crucial for the induction of Foxp3+CD4+CD25+ T cells and for the suppression of CII-reactive T-cell function in induction of oral tolerance to CII. These results demonstrate that the induction of IDO+ DCs in Peyer's patches plays an essential role in the induction of oral tolerance and may provide a new modality of immune-based treatments for autoimmune diseases.
###end p 73
###begin title 74
Abbreviations
###end title 74
###begin p 75
APC = antigen-presenting cell; bp = base pair; CIA = collagen-induced arthritis; CII = type II collagen; cpm = counts per minute; DC = dendritic cell; ELISA = enzyme-linked immunosorbent assay; IDO = indoleamine 2,3-dioxygenase; IFN = interferon; IL = interleukin; 1-MT = 1-methyl tryptophan; mAb = monoclonal antibody; MHC = major histocompatibility complex; PBS = phosphate-buffered saline; PCR = polymerase chain reaction; RT = reverse transcriptase; TGFbeta = transforming growth factor beta.
###end p 75
###begin title 76
Competing interests
###end title 76
###begin p 77
The authors declare that they have no competing interests.
###end p 77
###begin title 78
Authors' contributions
###end title 78
###begin p 79
M-JP and S-YM performed the experimental work and prepared the manuscript. Y-GC, M-LC, K-SP, and S-GC advised on the study. H-SP, Y-OJ, and S-HC performed the experimental work H-YK is the head of the laboratory, supervised the experimental work, and advised on the study. S-HP, and J-KM are the senior researchers, and they supervised the experimental work and advised on the study. All authors read and approved the final manuscript.
###end p 79
###begin title 80
Acknowledgements
###end title 80
###begin p 81
The authors are grateful to Professor Andrew H. Kang for providing the CII. This work was supported by a grant (R11-2002-098-01001-0) from the Korea Science and Engineering Foundation through the Rheumatism Research Center and by the Korean Research Foundation Grant (KRF-2005-217-E00003) funded by the Korean Government (MOEHRD, Basic Research Promotion Fund).
###end p 81
###begin article-title 82
Therapeutic potential of oral tolerance
###end article-title 82
###begin article-title 83
Anatomical basis of tolerance and immunity to intestinal antigens
###end article-title 83
###begin article-title 84
Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen
###end article-title 84
###begin article-title 85
Regulation of autoreactive T cell function by oral tolerance to self-antigens
###end article-title 85
###begin article-title 86
The thymus plays a role in oral tolerance in experimental autoimmune encephalomyelitis
###end article-title 86
###begin article-title 87
Oral tolerance and regulation of mucosal immunity
###end article-title 87
###begin article-title 88
Oral tolerance: overview and historical perspectives
###end article-title 88
###begin article-title 89
Importance of dose of type II collagen in suppression of collagen-induced arthritis by nasal tolerance
###end article-title 89
###begin article-title 90
Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen
###end article-title 90
###begin article-title 91
Oral tolerance: immune mechanisms and treatment of autoimmune diseases
###end article-title 91
###begin article-title 92
Induction of anergy or active suppression following oral tolerance is determined by antigen dosage
###end article-title 92
###begin article-title 93
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 42 44 42 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Antigen-induced, tolerogenic CD11c+, CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis
###end article-title 93
###begin article-title 94
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 37 39 37 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen
###end article-title 94
###begin article-title 95
Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease
###end article-title 95
###begin article-title 96
Dendritic cells and immune responses to orally administered antigens
###end article-title 96
###begin article-title 97
Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo
###end article-title 97
###begin article-title 98
###xml 56 62 <span type="species:ncbi:10090">murine</span>
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells
###end article-title 98
###begin article-title 99
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
###end article-title 99
###begin article-title 100
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
###end article-title 100
###begin article-title 101
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling
###end article-title 101
###begin article-title 102
###xml 16 18 12 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties
###end article-title 102
###begin article-title 103
Immune mechanisms of allergen-specific sublingual immunotherapy
###end article-title 103
###begin article-title 104
###xml 30 34 <span type="species:ncbi:10116">rats</span>
Collagen-induced arthritis in rats. Evaluation of early immunologic events
###end article-title 104
###begin article-title 105
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial
###end article-title 105
###begin article-title 106
The role of dendritic cell subsets in selection between tolerance and immunity
###end article-title 106
###begin article-title 107
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 25 30 <span type="species:ncbi:9606">human</span>
Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells
###end article-title 107
###begin article-title 108
###xml 33 38 <span type="species:ncbi:9606">human</span>
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase
###end article-title 108
###begin article-title 109
Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines
###end article-title 109
###begin article-title 110
###xml 5 7 5 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase
###end article-title 110
###begin article-title 111
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
###end article-title 111
###begin article-title 112
Modulation of tryptophan catabolism by regulatory T cells
###end article-title 112
###begin article-title 113
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice
###end article-title 113
###begin article-title 114
###xml 55 60 <span type="species:ncbi:9606">human</span>
Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye
###end article-title 114
###begin article-title 115
###xml 92 95 <span type="species:ncbi:10116">rat</span>
Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system
###end article-title 115
###begin article-title 116
Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma
###end article-title 116
###begin article-title 117
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?
###end article-title 117
###begin article-title 118
The cross-talk between dendritic and regulatory T cells: good or evil?
###end article-title 118
###begin article-title 119
Tolerogenic dendritic cells and the quest for transplant tolerance
###end article-title 119
###begin article-title 120
###xml 53 69 <span type="species:ncbi:5476">Candida albicans</span>
A crucial role for tryptophan catabolism at the host/Candida albicans interface
###end article-title 120
###begin article-title 121
###xml 10 15 10 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 37 42 <span type="species:ncbi:9606">human</span>
CD4(+)CD25high regulatory T cells in human pregnancy
###end article-title 121
###begin article-title 122
Inducing and expanding regulatory T cell populations by foreign antigen
###end article-title 122
###begin article-title 123
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3
###end article-title 123

